Susquehanna International Group, LLP Pfizer Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $42.8 Million - $48.5 Million	1,543,800 Added 5.8%	28,176,500 $815 Million
Q2 2024 Aug 15, 2024	SELL	$25.26 - $29.6 $82.9 Million - $97.2 Million	-3,283,500 Reduced 10.98%	26,632,700 $745 Million
Q1 2024 May 07, 2024	BUY	$25.89 - $29.73 $47.5 Million - $54.5 Million	1,833,100 Added 6.53%	29,916,200 $830 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $450 Million - $585 Million	17,232,200 Added 158.81%	28,083,100 $809 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $15.4 Million - $18 Million	479,400 Added 4.62%	10,850,900 $360 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $15.6 Million - $18.1 Million	-432,700 Reduced 4.0%	10,371,500 $380 Million
Q1 2023 May 16, 2023	BUY	$39.39 - $51.28 $107 Million - $140 Million	2,725,500 Added 33.74%	10,804,200 $441 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $35.8 Million - $46.8 Million	-858,400 Reduced 9.6%	8,078,700 $414 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $21.7 Million - $26.4 Million	-495,100 Reduced 5.25%	8,937,100 $391 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.